SENJU PHARMACEUTICAL CO., LTD. v. APOTEX, INC.

Civ. No. 12-159-SLR.

921 F.Supp.2d 297 (2013)

SENJU PHARMACEUTICAL CO., LTD., Kyorin Pharmaceutical Co., Ltd. and Allergan, Inc., Plaintiffs, v. APOTEX, INC. and Apotex Corp., Defendants.

United States District Court, D. Delaware.

February 6, 2013.


Attorney(s) appearing for the Case

Jack B. Blumenfeld, Esquire , and Maryellen Noreika, Esquire of Morris, Nichols, Arsht & Tunnell LLP, Wilmington, DE. Counsel for Plaintiffs. Of Counsel: Richard D. Kelly, Esquire , Stephen G. Baxter, Esquire , Frank J. West, Esquire , and Tia D. Fenton, Esquire of Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.

Francis J. Murphy, Esquire of Murphy & Landon, Wilmington, DE. Counsel for Defendants. Of Counsel: Alan B. Clement, Esquire , Scott B. Feder, Esquire , David B. Abramowitz, Esquire , and Patrick C. Gallagher, Esquire of Locke Lord LLP.


MEMORANDUM OPINION

SUE L. ROBINSON, District Judge.

I. INTRODUCTION

This action arises out of the filing of an Abbreviated New Drug Application ("ANDA") with the United States Food and Drug Administration ("FDA") by defendants Apotex, Inc. and Apotex Corp. (collectively, "Apotex"). Allergan, Inc. ("Allergan") is the holder of approved New Drug Application ("NDA") No. 22-548 that covers Zymaxid®, a 0.5% ophthalmic solution of gatifloxacin....

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases